Myrbetriq ER 50 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F9CXK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,975
Award facts
- Contract value 100% obligated
- $20,975.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $20,975.27 delivery order from the Defense Logistics Agency on January 9, 2026, for 90-count tablets of Myrbetriq ER 50 mg. The contract represents a firm fixed-price award with no set-aside designation, indicating competitive selection among qualified vendors. This delivery order is a child contract issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as the comprehensive vehicle for supplying pharmaceutical products and medical supplies to military healthcare systems worldwide.
The Defense Logistics Agency Medical Supply Chain utilizes the Cencora/AmerisourceBergen IDC to procure a diverse range of medications spanning multiple therapeutic domains, including specialty pharmaceuticals, brand-name and generic drugs, vaccines, and medical supplies critical to military treatment facilities and veteran healthcare programs. The award of this Myrbetriq delivery order demonstrates the contractor's ongoing capability to fulfill federal pharmaceutical procurement requirements and support the Defense Health Agency's medical supply needs. The ultimate completion date is scheduled for January 12, 2026, with performance to be completed at the awardee's Conshohocken, Pennsylvania location.
Quick answers
Who was awarded contract SPE2DR26F9CXK?
SPE2DR26F9CXK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F9CXK worth?
The government has obligated $20,975 on SPE2DR26F9CXK.
Is contract SPE2DR26F9CXK an order under another contract?
Yes. SPE2DR26F9CXK is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9CXK competed?
The extent of competition for SPE2DR26F9CXK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award